Travere Therapeutics, Inc. · NASDAQ:TVTX
Cline Christopher R. sold 8,327 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 13 to Apr 15, 2026 · Filed Apr 15, 2026
From Apr 13 to Apr 15, 2026, Cline Christopher R. (CHIEF FINANCIAL OFFICER) sold 8,327 Travere Therapeutics, Inc. shares at an average US$41.91 for US$349K under a trading plan, leaving 116,899 shares. Filed Apr 15, 2026 (Form 4).
- Sold
- 8,327 shares
- Price
- US$41.91 average (US$28.85 to US$42.61)
- Value
- US$349K
- Holding after
- 116,899 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | Award | 14,000 | 125,226 | Direct | |
| Apr 13, 2026 | Common Stock | Sale | 65 | US$28.85 | 125,161 | Direct |
| Apr 14, 2026 | Common Stock | Sale | 9 | US$41.07 | 125,152 | Direct |
| Apr 14, 2026 | Common Stock | Sale | 7,239 | US$41.93 | 117,913 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 1,014 | US$42.61 | 116,899 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Cline Christopher R.
- Travere Therapeutics, Inc. shareholders
- Form 4 · Cline Christopher R. · Sep 17, 2026
- Form 4 · Cline Christopher R. · Sep 3, 2026
- Form 4 · Cline Christopher R. · May 6, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026